Cetuximab trials for Pancreatic Ductal Adenocarcinoma (PDAC)

All Cetuximab trials · All Pancreatic Ductal Adenocarcinoma (PDAC) trials

Phase breakdown

Recruiting trials studying Cetuximab for Pancreatic Ductal Adenocarcinoma (PDAC)

• A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
  NCT07644559 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 29 locations
• A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
  NCT07223047 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 8 locations
• Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
  NCT07349537 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations

Common questions

How many trials study Cetuximab for Pancreatic Ductal Adenocarcinoma (PDAC)?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.